Talking About Glaucoma (AAC)

Visit https://TalkingAboutGlaucoma.com to find all my social feeds, subscribe to the newsletter, provide feedback and Register as a Guest if you want to be on a future episode.

More information about Dr Mahnia Madan can be found at https://www.talkingaboutglaucoma.com/guests/mahnia-madan/

This episode has been sponsored by Sun Pharma Canada Inc., which did not provide any material or exercise editorial control over the content.

In this episode, I talk with Abdullah “Abed” Sarhan, CEO and Co-founder of Retinal Logic, about the company's use of AR and VR technology for vision screening. Abbott shares his background in deep learning and healthcare, the development of the virtual reality prototype, the device's availability and Health Canada approval, and its differentiation from other companies' technologies. He also discusses the various test sizes and algorithms available, ongoing research, user experience, and the company's future roadmap.

Visit https://TalkingAboutGlaucoma.com to find all my social feeds, subscribe to the newsletter, provide feedback and Register as a Guest if you want to be on a future episode.

About Abbott Sahran and selected references can be found at: https://www.talkingaboutglaucoma.com/guests/abdullah-sarhan/

[Please change your subscription to the mp3 feed instead of the AAC feed as I will be stopping this AAC feed in 2024…see https://TalkingAbout Glaucoma.com for all the links to subscribe.]

In this episode, I go beyond the basics of Optical Coherence Tomography (OCT) with Dr Hady Saheb from McGill University. Our discussion includes Ganglion Cell Layer analysis, structure-function correlation, the floor effect, viewing-software vs printouts and explaining test results to patients.

Visit https://TalkingAboutGlaucoma.com to find all my social feeds, subscribe to the newsletter, provide feedback and Register as a Guest if you want to be on a future episode.

About Hady Saheb and selected references:
https://www.talkingaboutglaucoma.com/guests/hady-saheb/

Intro:

In this episode, I discuss Plateau Iris with Dr Shivani Kamat, Assistant Professor of Ophthalmology and Glaucoma Fellowship Program director at UT Southwestern. She also founded and co-chairs Women in Glaucoma. Today's discussion includes the difference between plateau iris configuration and syndrome, how to distinguish it from other glaucomas and treatment options.

Outro:

Talking About Glaucoma is a podcast of indeterminate frequency and duration...recently averaging 4 episodes per year. I'm still hoping to get this out monthly in the future. It’s free on Apple Podcasts, Spotify, Google Podcasts, PocketCasts, Podcast Addict, and many other podcast services. Please rate the podcast on your podcast player of choice, subscribe to it, and tell your friends about it so that it can reach more listeners and encourage me to continue to produce new episodes. Follow me at WestCoastGlaucoma on Instagram and Talking About Glaucoma on Facebook. Drop me a line at [email protected] with your show ideas, if you would like to be on a future episode or questions you would like to have answered on future episodes. Keep informed to prevent needless loss of vision from glaucoma. See you next time on Talking About Glaucoma.

About Shivani Kamat (taken from the UT Southwestern Medical Centre website):

Shivani Kamat, M.D., is an Assistant Professor in the Department of Ophthalmology and Director of the Glaucoma Fellowship at UT Southwestern Medical Center. She specializes in complex glaucoma, anterior segment disease, minimally invasive glaucoma surgery, and cataract surgery and has extensive experience in medical, laser, and surgical treatment of glaucoma, including combined cataract and glaucoma procedures as well as the latest glaucoma surgical devices and intraocular lens implant technology.

Dr. Kamat earned her medical degree at the University of Florida in Gainesville. She completed an internship in internal medicine at the UF Health Shands Hospital, a residency in ophthalmology at Loyola University, and a fellowship in glaucoma at Massachusetts Eye and Ear, a primary teaching hospital of Harvard Medical School.

Certified by the American Board of Ophthalmology, she joined the UT Southwestern faculty in 2022. Previously, she was an Assistant Professor at the University of Michigan Kellogg Eye Center in Ann Arbor, where she served as the Glaucoma Fellowship Director and the Medical Director of the center’s community clinic in Brighton, Michigan.

Dr. Kamat founded and co-chairs Women in Glaucoma. She serves on multiple committees of the American Glaucoma Society and as an examiner for the American Board of Ophthalmology. She is also a member of the American Academy of Ophthalmology, the American Society of Cataract and Refractive Surgery, and the Dallas Academy of Ophthalmology.

Dr. Kamat is actively involved in clinical research; her interests include the epidemiology of glaucoma, minimally invasive glaucoma surgery, anterior segment disease, and plateau iris syndrome. She has lectured widely and published numerous research articles on these and related topics in publications such as Nature, Ophthalmology, JAMA Ophthalmology, Journal of Glaucoma, and EyeNet Magazine. In addition, she has served as a reviewer for the Journal of Glaucoma, contributed to a book on gonioscopy-assisted transluminal trabeculotomy, and been interviewed for stories in national magazines and digital platforms.

Selected references:

Shivani S Kamat, Helen L Kornmann, Kugler Publications. GATT in Secondary Glaucoma in GATT: Gonioscopy Assisted Transluminal Trabeculotomy- A Guide to Circumnavigating Schlemm's Canal from Around the World

SS Kamat, MS Gregory, LR Pasquale - Seminars in ophthalmology, 2016 - Taylor & Francis. The role of the immune system in glaucoma: bridging the divide between immune mechanisms in experimental glaucoma and the human disease

JR Ehrlich, AR Elam, D John, SS Kamat… - JAMA …, 2020 - jamanetwork.com Application of the sight outcomes research collaborative ophthalmology data repository for triaging patients with glaucoma and clinic appointments during pandemics

SJ Garnai, LA Huryn, K Johnson, SS Kamat… - Scientific reports, 2020 - nature.com Novel TMEM98, MFRP, PRSS56 variants in a large United States high hyperopia and nanophthalmos cohort

M Rahman, C Andrews, JR Ehrlich, S Kamat… - JAMA …, 2019 - jamanetwork.com Evaluation of an algorithm for identifying ocular conditions in electronic health record data

 WS Lieb, G Fabry, KN Allen, SS Kamat… - … & Visual Science, 2017 - arvojournals.org The ability of nitric oxide to lower intraocular pressure is dependent on guanylyl cyclase

JA Musser, LM Niziol, MM Heisler, SS Kamat… - Journal of …, 2019 - ncbi.nlm.nih.gov Integrating patient education into the glaucoma clinical encounter: a lean analysis

MM Shah, AR Elam, SS Kamat… - Clinical …, 2020 - Taylor & Francis The appropriateness of digital diabetic retinopathy screening images for a computer-aided glaucoma screening system

Production information:

This episode was recorded back on April 22, 2022 over Zoom. Mixing was finally completed March 20, 2023 using Hindenberg Journalist Pro software iZotope processing plug-ins on a Gigabyte AERO 17 computer. The narration was overdubbed using a Heil PR40 microphone through an SSL 2 USB Audio.

The opinions expressed in this podcast are those of the speakers and are not intended to be taken as the standard of care for glaucoma treatment. Please always weigh the complete clinical picture and involve patients with any decisions in their care.

Robert M Schertzer, MD, MEd, FRCSC
[email protected]

Twitter - https://twitter.com/robschertzer
or http://iguy.tv/twitter

Blog - http://wholelottarob.com
or http://iguy.tv/blog

Facebook - https://facebook.com/talkingaboutglaucoma

Office website - https://westcoastglaucoma.com
or http://iguy.tv/office

YouTube channel - https://youtube.com/robschertzer

Instagram - https://instagram.com/westcoastglaucoma

Theme music “Middle East Gold” ©Daniel Schertzer 2010 and published by Les Prods DOSWA Enr

© 2023 DOSWA Prods Enr/Robert M Schertzer MD. MEd, FRCSC

iTunes Subtitle:

A discussion with Shivani Kamat about Plateau Iris. The discussion includes the difference between plateau iris configuration and syndrome, how to distinguish plateau iris from other glaucoma and its implication for treatment options.

iTunes Summary:

In this episode, I talk with Dr Shivani Kamat, Associate Professor of Ophthalmology and Glaucoma Fellowship Program director at UT Southwestern, about Plateau Iris. The discussion includes the difference between plateau iris configuration and syndrome, how to distinguish plateau iris from other glaucoma and its implication for treatment options.

SEO Title

Discussion with Shivani Kamat about Plateau Iris

SEO Description

The discussion includes the difference between plateau iris configuration and syndrome, how to distinguish plateau iris from other glaucoma and its implication for treatment options.

iTunes TAG 37

Intro:
In this episode, I talk with Carla Siegfried, Jacquelyn E. and Allan E. Kolker, MD Distinguished Professor of Ophthalmology and Vice-Chair of Diversity, Equity, and Professionalism at Washington University School of Medicine, about the gold standard glaucoma surgical procedure: the trabeculectomy. We exchange detailed tips for success for each step of the surgery and post-operative care. It is clear from our discussion that we must continue to train others so that the trabeculectomy does not become a lost art. This is a procedure requiring no special devices and remains the gold standard for achieving low pressures despite its higher complication rate compared to other procedures.

There are some audio issues with the recording of this episode that I've cleaned up as best I can. I'm Rob Schertzer, a Vancouver, Canada-based glaucoma specialist, podcaster and HealthIT expert, and we're...talking about glaucoma.

Outro:
Talking About Glaucoma is a podcast of indeterminate frequency and duration...recently averaging 4 episodes per year. I'm still hoping to get this out monthly in the future. It’s available for free on Apple Podcasts, Spotify, Google Podcasts, PocketCasts, Podcast Addict, and many other podcast services. Please rate the podcast on your podcast player of choice, subscribe to it, and tell your friends about it, so that it can reach more listeners and encourage me to continue to produce new episodes. Follow me at WestCoastGlaucoma on Instagram and Talking About Glaucoma on Facebook. Drop me a line at [email protected] with your show ideas, if you would like to be on a future episode or questions you would like to have answered on future episodes. Keep informed to prevent needless loss of vision from glaucoma. See you next time on Talking About Glaucoma.

--------

About Carla Siegfried:
Carla J. Siegfried, MD
Jacquelyn E. and Allan E. Kolker, MD Distinguished Professor of Ophthalmology
Vice Chair of Diversity, Equity, and Professionalism
John F. Hardesty, MD Department of Ophthalmology and Visual Sciences
Washington University School of Medicine
660 South Euclid Ave.
MSC-8096-05-721
St. Louis, MO 63110
314-362-3937
[email protected]


Selected references from past 5 years:
1: Ban N, Siegfried CJ, Apte RS. Monitoring Neurodegeneration in Glaucoma:
Therapeutic Implications. Trends Mol Med. 2018 Jan;24(1):7-17. doi:
10.1016/j.molmed.2017.11.004. Epub 2017 Dec 7. PMID: 29233479; PMCID:
PMC5748344.

2: Siegfried CJ. Setting the Gold(en) Standard for Ethical Care:
#PatientCommunication. Ophthalmology. 2019 Mar;126(3):335-337. doi:
10.1016/j.ophtha.2018.09.011. Epub 2018 Sep 19. PMID: 30240792.

3: Van Gelder RN, Siegfried CJ. ROI, COI, and the Ethical Obligations of
Journals. Ophthalmology. 2022 Jun;129(6):602-604. doi:
10.1016/j.ophtha.2022.04.007. PMID: 35598900.

4: De Maria A, Zientek KD, David LL, Wilmarth PA, Bhorade AM, Harocopos GJ,
Huang AJW, Hong AR, Siegfried CJ, Tsai LM, Sheybani A, Bassnett S. Compositional
Analysis of Extracellular Aggregates in the Eyes of Patients With Exfoliation
Syndrome and Exfoliation Glaucoma. Invest Ophthalmol Vis Sci. 2021 Dec
1;62(15):27. doi: 10.1167/iovs.62.15.27. PMID: 34964803; PMCID: PMC8740535.

5: Pelton RW, Siegfried CJ. Re: Bartley: Verifying surgical competence: our
fiduciary responsibility (Ophthalmology. 2020;127:997-999). Ophthalmology. 2020
Dec;127(12):e111-e112. doi: 10.1016/j.ophtha.2020.06.022. Epub 2020 Jul 29.
PMID: 32739188.

6: Siegfried CJ, Shui YB. Intraocular Oxygen and Antioxidant Status: New
Insights on the Effect of Vitrectomy and Glaucoma Pathogenesis. Am J Ophthalmol.
2019 Jul;203:12-25. doi: 10.1016/j.ajo.2019.02.008. Epub 2019 Feb 15. PMID:
30772349; PMCID: PMC6612589.

7: Siegfried CJ, Shui YB, Tian B, Nork TM, Heatley GA, Kaufman PL. Effects of
Vitrectomy and Lensectomy on Older Rhesus Macaques: Oxygen Distribution,
Antioxidant Status, and Aqueous Humor Dynamics. Invest Ophthalmol Vis Sci. 2017
Aug 1;58(10):4003-4014. doi: 10.1167/iovs.17-21890. PMID: 28800647; PMCID:
PMC5555251.


—————————————————————————
Production information:

This episode was recorded February 29, 2020 during the Annual Meeting of the American Glaucoma Society in Washington, DC, unfortunately using a BOYA Dual Lapel USB-C Microphone BY-M3D - which I do not recommend. Mixing was finally completed to salvage the recording on May 9, 2022 using Hindenberg Journalist Pro software iZotope processing plug-ins on a Gigabyte AERO 17 computer. The narration was overdubbed using a Heil PR40 microphone through an SSL 2 USB Audio Interface onJune 6, 2022.

The opinions expressed in this podcast are those of the speakers and are not intended to be taken as the standard of care for glaucoma treatment. Please always weigh the complete clinical picture and involve patients with any decisions in their care.

Robert M Schertzer, MD, MEd, FRCSC
[email protected]
Twitter - https://twitter.com/robschertzer
or http://iguy.tv/twitter
Blog - http://wholelottarob.com
or http://iguy.tv/blog
Facebook - https://facebook.com/talkingaboutglaucoma
Office website - https://westcoastglaucoma.com
or http://iguy.tv/office
YouTube channel - https://youtube.com/robschertzer
Instagram - https://instagram.com/westcoastglaucoma

Theme music “Middle East Gold” ©Daniel Schertzer 2010 and published by Les Prods DOSWA Enr

© 2022 DOSWA Prods Enr/Robert M Schertzer MD. MEd, FRCSC

TAG #35 GEDDE Steve - Glaucoma surgical trials: lessons learned
Intro:
There have been many trials proving surgical intervention does indeed reduce the risk of progressive glaucoma damage for our patients. These include Treatment vs No Treatment studies as well as studies that compare different types of treatment. In this episode, I talk with Steve Gedde, from the University of Miami's Bascom Palmer Eye Institute, about lessons learned from these clinical trials.

We begin by discussing the importance of Randomized Clinical Trials as the highest evidence-based medicine to compare treatments.

Studies that we discuss include: the Fluorouracil Filtering Study Group; Tube vs Trab (TVT); Primary Tube vs Trab (PTVT); Ahmed Baervedlt Comparison (ABC); Ahmed vs Baerveldt.

Some of the concepts and lessons learned include: reducing IOP prior to surgery to lessen the risk of choroidal hemorrhage from a sudden IOP drop; trabeculectomy offering titratable control that MIGS procedures do not; that it's harder to get a 20% reduction in IOP to count as a success if the IOP is lower than 25 pre-op; that Ahmed Valves have a better safety record but Baerveldt better pressure-lowering; and that antimetabolites have been shown to NOT be effective for tube-shunt surgery.

There's quite a bit of information packed into this episode so I suggest checking the program notes for links to some relevant articles and presentations related to this topic.

I'm Rob Schertzer, a Vancouver, Canada based glaucoma specialist, podcaster and HealthIT expert, and we're...talking about glaucoma.

Outro:
Talking About Glaucoma is a podcast of indeterminate frequency and duration. It’s available for free on Apple Podcasts, Spotify, Google Podcasts, PocketCasts, and many other podcast services. Please rate the podcast on Apple Podcasts, subscribe to it, and tell your friends about it, so that it can reach more listeners and encourage me to continue to produce new episodes. Follow WestCoastGlaucoma on Instagram and Talking About Glaucoma on Facebook. Drop me a line at [email protected] with your show ideas or questions you would like to have answered on future episodes. Keep informed to prevent needless loss of vision from glaucoma. See you next time on Talking About Glaucoma.

--------
Steve Gedde is Professor of Ophthalmology, the John G. Clarkson Chair in Ophthalmology, Vice-Chair of Education and Residency Program Director at Bascom Palmer.
--------
We spoke in February 2020, one of three interviews I recorded at the last in-person American Glaucoma Society annual meeting prior to Covid. My apologies that all of these recordings were made using BOYA Dual Lapel USB-C BY-M3D mics plugged into an Android phone instead of my usual professional set-up. I've done my best to make the audio quality acceptable but the sound quality is not up to my usual high standards. Fortunately there is just one more episode with this low quality...so be sure to subscribe so you can get the good stuff when available.
--------
I'm Rob Schertzer, a Vancouver-based Glaucoma specialist, EMR guru and tech geek and we're...talking about glaucoma.

About Steve Gedde:
https://doctors.umiamihealth.org/provider/Steven+J+Gedde/524953
Professor of Ophthalmology
John G. Clarkson Chair in Ophthalmology
Vice Chair of Education and Residency Program Director

Selected references:
This link may have restricted access to American Glaucoma Society members. It is a lecture that Dr. Gedde delivered at the March 2020 AGS Annual Meeting in Washington DC entitled: Lessons Learned from Glaucoma Surgical Trials
https://www.aao.org/annual-meeting-video/lessons-learned-from-glaucoma-surgical-trials

Here is a reasonably comprehensive list of glaucoma clinical trials, broken down as Treatment vs No Treatment and Treatment vs Treatment
https://eyewiki.aao.org/Clinical_Trials_in_Glaucoma

—————————————————————————
Production information:

This episode was recorded February 29, 2020 during the Annual Meeting of the American Glaucoma Society in Washington, DC, unfortunately using a BOYA Dual Lapel USB-C Microphone BY-M3D - which I do not recommend. Mixing and sound levelling were finally completed to salvage the recording on February 21, 2022 using Hindenberg Journalist Pro software iZotope processing plug-ins on a Gigabyte AERO 17 computer. The narration was overdubbed using a Heil PR40 microphone.

Opinions expressed in this podcast are those of the speakers and are not intended to be taken as the standard of care for glaucoma treatment. Please always weigh the complete clinical picture and involve patients with any decisions in their care.

Robert M Schertzer, MD, MEd, FRCSC
[email protected]
Twitter - https://twitter.com/robschertzer
or http://iguy.tv/twitter
Blog - http://wholelottarob.com
or http://iguy.tv/blog
Facebook - https://facebook.com/talkingaboutglaucoma
Office website - https://westcoastglaucoma.com
or http://iguy.tv/office
YouTube channel - https://youtube.com/robschertzer
Instagram - https://instagram.com/westcoastglaucoma

Theme music “Middle East Gold” ©Daniel Schertzer 2010 and published by Les Prods DOSWA Enr

© 2022 DOSWA Prods Enr/Robert M Schertzer MD. MEd, FRCSC
—————————————————————————
iTunes Subtitle:
A talk with Steve Gedde on lessons learned from glaucoma surgery randomized controlled trials.

iTunes Summary:
In this episode, I talk with Steve Gedde, from the University of Miami's Bascom Palmer Eye Institute, about lessons learned from these clinical trials.

We begin by discussing the importance of Randomized Clinical Trials as the highest evidence-based medicine to compare treatments. Studies that we discuss include: the Fluorouracil Filtering Study Group; Tube vs Trab (TVT); Primary Tube vs Trab (PTVT); Ahmed Baervedlt Comparison (ABC); Ahmed vs Baerveldt.

Some of the concepts and lessons learned include: reducing IOP prior to surgery to lessen the risk of choroidal hemorrhage from a sudden IOP drop; trabeculectomy offering titratable control that MIGS procedures do not; that it's harder to get a 20% reduction in IOP to count as a success if the IOP is lower than 25 pre-op; that Ahmed Valves have a better safety record but Baerveldt better pressure-lowering; and that antimetabolites have been shown to not be effective for tube-shunt surgery.

Intro: Welcome to Talking About Glaucoma episode #34 for May 7, 2021. Here’s another recording from the vaults that is getting to see the light of day. It is one of 3 episodes recorded in person back in late February 2020 just before Covid de-railed us all from business as usual. My apologies for the sound quality on this one; I was experimenting with a BOYA dual lapel mic, recording directly into my phone: big mistake! Future recordings from episode 37 onward will go back to my professional recording gear.

Email me at [email protected] if you would like to be on the show to discuss a topic in glaucoma or if you have questions that you would like to have answered on a future episode. Check out WestCoastGlaucoma on Instagram https://instagram.com/westcoastglaucoma for some short-form videos that can also be found on my robschertzer YouTube channel. https://youtube.com/robschertzer where your subscription will help improve future content.

In this episode, I talk with Daniel Laroche. We have crossed paths for many years at conferences having both started our practices at the same time, but this was the first time we sat down to record our conversation. Daniel Laroche is Director of Glaucoma Services and President of Advanced Eyecare of New York. He is affiliated with the New York Eye and Ear Infirmary, and Assistant Professor of Ophthalmology at the Mount Sinai School of Medicine, New York. I'm Rob Schertzer, a Vancouver, Canada based glaucoma specialist, podcaster and HealthIT expert, and we're...talking about glaucoma.

Outro:

That’s our show for today! Talking About Glaucoma is a podcast of indeterminate frequency and duration. It’s available for free on Apple Podcasts, Spotify, Google Podcasts, PocketCasts, and wherever fine podcasts are curated. Please rate the podcast on Apple Podcasts, subscribe to it, and tell your friends about it, so that it can reach more listeners. Follow me at WestCoastGlaucoma on Instagram, Talking About Glaucoma on Facebook and robschertzer on YouTube. Drop me a line at [email protected] with your show ideas or questions you would like to have answered on future episodes. Keep informed to prevent needless loss of vision from glaucoma, stay safe, wear a mask and get vaccinated. See you next time on Talking About Glaucoma.

—————————————————————————

About our guest

Daniel Laroche is Director of Glaucoma Services and President of Advanced Eyecare of New York (https://www.advancedeyecareny.com). He is affiliated with the New York Eye and Ear Infirmary, and Assistant Professor of Ophthalmology at the Mount Sinai School of Medicine, New York (https://www.mountsinai.org/profiles/daniel-laroche2).

YouTube videos

Ciliary Body Suprachoroidal Microtube https://youtu.be/34WPtWZ7SeE
Combined Goniotomy and SC Microtobue https://youtu.be/IVe95AvBHfA

Publications by Daniel Laroche:

Real World Outcomes of Kahook Dual Blade Goniotomy in Black and Afro-Latinx Adult Patients with Glaucoma: A 6-Month Retrospective Study

The Aging Lens and Glaucoma in persons over 50: Why early cataract surgery/refractive lensectomy and microinvasive trabecular bypass can prevent blindness and cure elevated eye pressure

Combination microinvasive glaucoma surgery: 23-gauge cystotome goniotomy and intra-scleral ciliary sulcus suprachoroidal microtube surgery in refractory and severe glaucoma: A case series

Clear Lensectomy, Goniosynechiolysis and Hydrus Microstent in a Patient with Mixed Mechanism Glaucoma

Preserving vision in the COVID-19 pandemic: Focus on health equity

Combined microinvasive glaucoma surgery in osteogenesis imperfecta patient with refractory open angle glaucoma

Real-world retrospective consecutive study of ab interno XEN 45 gel stent implant with mitomycin C in black and afro-latino patients with glaucoma: 40% required secondary glaucoma surgery at 1 year

Intra-Scleral Ciliary Sulcus Suprachoroidal Microtube: Making Supraciliary Glaucoma Surgery Affordable

A Novel Low Cost Effective Technique in Using a 23 Gauge Straight Cystotome to Perform Goniotomy: Making Micro-invasive Glaucoma Surgery (MIGS) Accessible to the Africans and the Diaspora

A novel use of trypan blue during canalicular glaucoma surgery to identify aqueous outflow to episcleral and intrascleral veins

—————————————————————————

Production information:

This episode was recorded February 28, 2020 during the Annual Meeting of the American Glaucoma Society in Washington, DC. In a first for me, I recorded direct to a Huawei Mate20 Pro running Easy Voice Recorder Pro using a BOYA BY-M3D dual lapel microphone. As you will hear, this was a mistake but unfortunately I used this same recording setup for the next two episodes as well. After that, I’ll go back to my Shure SM58 microphones and Marantz recorder!  Mixing and sound levelling were finally completed May 5, 2021 on an M1 MacMini using Hindenberg Journalist Pro software and Flux Software sound processing. Narration was overdubbed using a HEIL PR40 microphone.

Opinions expressed in this podcast  are those of the speakers and are not intended to be taken as the standard of care for glaucoma treatment. Please always weigh the complete clinical picture and involve patients with any decisions in their care.

Robert M Schertzer, MD, MEd, FRCSC
[email protected]

Twitter - https://twitter.com/robschertzer
or http://iguy.tv/twitter

Blog -     http://wholelottarob.com
or http://iguy.tv/blog

Facebook - https://facebook.com/talkingaboutglaucoma

Office website - https://westcoastglaucoma.com
or http://iguy.tv/office

YouTube channel - https://youtube.com/robschertzer

Instagram - https://instagram.com/westcoastglaucoma

Theme music “Middle East Gold” ©Daniel Schertzer 2010 and published by Les Prods DOSWA Enr

© 2021 DOSWA Prods Enr/Robert M Schertzer MD. MEd, FRCSC

—————————————————————————

Intro: Welcome to Talking About Glaucoma episode #33 for December 31, 2020. I bet you're glad this year is over! I'm still digging through the vaults to post episodes like this gem and have a few more that will go live soon. Email me at [email protected] if you would like to be on the show to discuss a topic in glaucoma or if you have questions that you would like to have answered on a future episode. Check out WestCoastGlaucoma on Instagram https://instagram.com/westcoastglaucoma for some short-form videos that can also be found on my robschertzer YouTube channel. https://youtube.com/robschertzer.

In this episode, I talk with Gus DeMoraes, a frequent guest of the pod. Gus is Associate Professor of Ophthalmology at Columbia University where he serves as Medical Director of Clinical Trials. When we originally sat down to record this way back in March 2019, he had just presented some of the work he had done in collaboration with Don Hood. This has now appeared on Humphrey perimeters as the 24-2C testing strategy and is becoming a new the standard of care. It is based on reports in recent years that glaucoma damage often occurs in the macular area but missed because the standard 24-2 testing strategy only tests in 6 degree increments. These early central glaucomatous defects are often hidden between the test points. Listen in as I talk with Gus.

I'm Rob Schertzer, a Vancouver, Canada based glaucoma specialist, podcaster and HealthIT expert, and we're...talking about glaucoma.

Outro: Talking About Glaucoma is a podcast of indeterminate frequency and duration. It’s available for free on Apple Podcasts, Spotify, Google Podcasts, PocketCasts, and many other podcast services. Please rate the podcast on Apple Podcasts, subscribe to it, and tell your friends about it, so that it can reach more listeners. Follow WestCoastGlaucoma on Instagram and Talking About Glaucoma on Facebook. Drop me a line at [email protected] with your show ideas or questions you would like to have answered on future episodes. Keep informed to prevent needless loss of vision from glaucoma, stay safe, wear a mask and get vaccinated. See you next time on Talking About Glaucoma.

—————————————————————————

About our guest:

Gus DeMoraes: https://www.columbiaeye.org/profile/cgdemoraes?profile=researcher

Relevant publications

DE MORAES CG, Sun A, Jarukasetphon R, Rajshekhar R, Shi L, Blumberg DM, Liebmann JM, Ritch R, Hood DC. Association of Macular Visual Field Measurements With Glaucoma Staging Systems. JAMA Ophthalmol. 2018 Nov 8 [Epub ahead of print]

Mavrommatis MA, Wu Z, Naegele SI, Nunez J, DE MORAES CG, Ritch R, Hood DC. Deep Defects Seen on Visual Fields Spatially Correspond Well to Loss of Retinal Nerve Fiber Layer Seen on Circumpapillary OCT Scans. Invest Ophthalmol Vis Sci. 2018;59(2):621-628

Garg A, DE MORAES CG, Cioffi GA, Girkin CA, Medeiros FA, Weinreb RN, Zangwill L, Liebmann JM. Baseline 24-2 Central Visual Field Damage is Predictive of Global Progressive Field Loss. Am J Ophthalmol. 2018;187:92-98

—————————————————————————

Production information:

This episode was recorded March 17, 2019 during the Annual Meeting of the American Glaucoma Society in San Francisco using two Shure SM58 microphones with a Marantz PMD661 digital recorder. Mixing and sound levelling were finally completed December 30, 2020 on an HP Spectre x360 laptop using Hindenberg Journalist Pro software and Flux Software sound processing. Narration was overdubbed using an Audio-Technica ATR2100-USB.

Opinions expressed in this podcast are those of the speakers and are not intended to be taken as the standard of care for glaucoma treatment. Please always weigh the complete clinical picture and involve patients with any decisions in their care.

Robert M Schertzer, MD, MEd, FRCSC
[email protected]

Twitter - https://twitter.com/robschertzer
or http://iguy.tv/twitter

Blog - http://wholelottarob.com
or http://iguy.tv/blog

Facebook - https://facebook.com/talkingaboutglaucoma

Office website - https://westcoastglaucoma.com
or http://iguy.tv/office

YouTube channel - https://youtube.com/robschertzer

Instagram - https://instagram.com/westcoastglaucoma

Theme music “Middle East Gold” ©Daniel Schertzer 2010 and published by Les Prods DOSWA Enr

© 2020 DOSWA Prods Enr/Robert M Schertzer MD. MEd, FRCSC

—————————————————————————

iTunes Subtitle:

A talk with Gus DeMoraes on the development of the Humphrey 24-2C testing strategy.

iTunes Summary:

In this episode, I talk with Gus DeMoraes, a frequent guest of the pod. Gus is Associate Professor of Ophthalmology at Columbia University where he serves as Medical Director of Clinical Trials. When we originally sat down to record this way back in March 2019, he had just presented some of the work he had done in collaboration with Don Hood. This has now appeared on Humphrey perimeters as the 24-2C testing strategy and is becoming a new the standard of care. It is based on reports in recent years that glaucoma damage often occurs in the macular area but missed because the standard 24-2 testing strategy only tests in 6 degree increments. These early central glaucomatous defects are often hidden between the test points.

I'm Rob Schertzer, a Vancouver, Canada based glaucoma specialist, podcaster and HealthIT expert, and we're...talking about glaucoma.

Intro:

My apologies for the >1 year gap since my last episode. It's been quite the year moving my work back to full time in Vancouver and providing patient care in our new normal of a pandemic. There are many more episodes that have been recorded; I'll keep trying to get them posted more often. Email me at [email protected] if you would like to be on the show.

In this episode, I talk with Won Kim, a glaucoma colleague based at Walter Reed National Military Medical Center and Hospital in Bethesda, Maryland, about why he has been combining multiple minimally invasive glaucoma procedures in patients who have failed traditional glaucoma surgery. I'm Rob Schertzer, a Vancouver, Canada based glaucoma specialist, podcaster and HealthIT expert, and we're...talking about glaucoma.

Outro:

Talking About Glaucoma is a podcast of indeterminate frequency and duration. It’s available for free on Apple Podcasts, Spotify, Google Podcasts, PocketCasts, and many other podcast services. Please rate the podcast on Apple Podcasts and tell your friends about it, so that it can reach more listeners. Drop me a line at [email protected] with your show ideas.

—————————————————————————

Production information:

This episode was recorded March 16, 2019 during the Annual Meeting of the American Glaucoma Society in San Francisco using two Shure SM58 microphones with a Marantz PMD661 digital recorder. Mixing and sound levelling were finally completed September 9, 2020 on a home brewed Windows X computer using Hindenberg Journalist Pro software and Flux Audio plug-ins. Narration was overdubbed using a Blue Yeti Microphone.

Opinions expressed in this podcast are those of the speakers and are not intended to be taken as the standard of care for glaucoma treatment. Please always weigh the complete clinical picture and involve patients with any decisions in their care.

Robert M Schertzer, MD, MEd, FRCSC
[email protected]

Twitter - http://twitter.com/robschertzer or http://iguy.tv/twitter

Blog - http://wholelottarob.com or http://iguy.tv/blog

Facebook - http://facebook.com/talkingaboutglaucoma

Office website - http://westcoastglaucoma.com

or http://iguy.tv/office

Theme music “Middle East Gold” ©Daniel Schertzer 2010 and published by Les Prods DOSWA Enr

© 2020 DOSWA Prods Enr/Robert M Schertzer MD. MEd, FRCSC

—————————————————————————

Today’s guest:

Won I. Kim, MD

MD: George Washington University School of Medicine

Ophthalmology Residency: San Antonio Uniformed Services Health Education Consortium

Glaucoma Fellowship: Bascom Palmer Eye Institute

Current: Program Director, Walter Reed National Military Medical Center, National Capital Consortium Ophthalmology Residency

[email protected]

—————————————————————————

iTunes Subtitle:

A talk with Won I. Kim, a staff Ophthalmologist and Glaucoma Specialist at Walter Reed in Bethesda, MD, discussing combined minimally invasive glaucoma surgeries as an option for treatment of glaucoma that has failed traditional surgeries.

iTunes Summary:

In this episode, I talk with Won Kim, a glaucoma colleague based on Walter Reed in Bethesda, Maryland, about how he has been combining multiple minimally invasive glaucoma procedures in patients who have failed traditional glaucoma surgery. I'm Rob Schertzer, a Vancouver, Canada based glaucoma specialist, podcaster and HealthIT expert, and we're...talking about glaucoma.

The goal of the late Dave Epstein was to find a drug that treats the cause of glaucoma by improving trabecular meshwork outflow. After many years of research, Aerie Pharmaceuticals was formed and refined a Rho Kinase inhibitor called Netarsudil. In April 2018 this came to market as Rhopressa and March 2019, combined with latanoprost, as Roclatan. Today I’m talking with Rick Lewis, a glaucoma colleague based in Sacramento and Chief Medical Officer for Aerie Pharmaceuticals…and we’re Talking About Glaucoma.

Talking About Glaucoma is a podcast of indeterminate frequency and duration. It’s available for free on Apple Podcasts, Google Podcasts, PocketCasts, and many other podcast services. Please rate the podcast on Apple Podcasts and tell your friends about it, so that it can reach more listeners. Drop me a line at [email protected] with your show ideas.

—————————————————————————
Selected links:

https://aeriepharma.com/
https://clinicaltrials.gov/ct2/show/NCT02246764

—————————————————————————
Production information:

This episode was recorded March 2019 during the Annual Meeting of the American Glaucoma Society in San Francisco using two Shure SM58 microphones with a Marantz PMD661 digital recorder. Mixing and sound levelling were completed June 2019 on an iMac using Hindenberg Journalist Pro software. Narration was overdubbed using a Blue Yeti Microphone.

Opinions expressed in this podcast are those of the speakers and are not intended to be taken as the standard of care for glaucoma treatment. Please always weigh the complete clinical picture and involve patients with any decisions in their care.

Robert M Schertzer, MD, MEd, FRCSC
[email protected]

Twitter - http://twitter.com/robschertzer
or http://iguy.tv/twitter

Blog - http://wholelottarob.com
or http://iguy.tv/blog

Facebook - http://facebook.com/talkingaboutglaucoma

Office website - http://westcoastglaucoma.com
or http://iguy.tv/office

Theme music “Middle East Gold” ©Daniel Schertzer 2010 and published by Les Prods DOSWA Enr

© 2019 DOSWA Prods Enr/Robert M Schertzer MD. MEd, FRCSC

—————————————————————————

Today’s guest:
Richard A. Lewis, MD
Sacramento Eye Consultants
1515 River Park Drive, Suite 100, Sacramento, CA 95815
Tel: 1-916-649-1515
[email protected]
https://www.sacramentoeyeconsultants.com/sacramento/our-doctors/richard-a-lewis-md.htm

—————————————————————————